NCTR, Division of Neurotoxicology

The National Center for Toxicological Research (NCTR) is the primary research center of the U.S. Food and Drug Administration. The one-million square foot research campus in Jefferson, Arkansas plays a critical role in the missions of FDA and the Department of Health and Human Services to promote and protect public health.

Equipment:

Primary Contact – Dr. Serguei Liachenko, M.D., Serguei.Liachenko@fda.hhs.gov, https://www.fda.gov/node/373301

  • Bruker 47/40 MRI (4.7T) – Non-human primate MRI
  • Bruker Advance III 500 (70/30 MRI, or 7T MRI) – Rodent MRI

Primary Contact – Dr. Xuan Zhang, M.D., xuan.zhang@fda.hhs.gov, https://www.fda.gov/node/373323

  • Samsung Neurologica CT scanner and data collection
  • MicroPET Focus 220

Primary Contact – Dr. Syed Imam, M.S., syed.imam@fda.hhs.gov, https://www.fda.gov/node/373319

  • Harvard Bioscience MEA-VMT2 Micro Electrode Array (MEA) Equipment – in vitro and in vivo extracellular recordings and electrical stimulation

Primary Contact – Dr. John Talpos, john.talpos@fda.hhs.gov, https://www.fda.gov/node/373305

  • Med operant test systems – Non-human primate behavior

All potential use of NCTR equipment must be aligned with NCTR’s mission and may require a technology transfer agreement:

NCTR conducts scientific research to generate data for FDA decision making, and develops and supports innovative tools and approaches that FDA uses to protect and promote individual and public health.

 

If you would like to contact this core facility, please fill out the "Facility Contact Form" on the right of this page. This contact method helps ARA measure the success of the CFE in connecting potential collaborators and will flow directly to the core director’s email inbox.